MedTrace Logo

Eosinophil Indices in Patients With Acute Heart Failure

NCT05410990 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 395

Last updated 2022-06-08

No results posted yet for this study

Summary

All consecutive patients admitted to the intensive care unit (ICU) with ADHF between January 2017 and December 2021 were enrolled in this retrospective study. All-cause mortality and MACE were assessed with respect to relationships with eosinophil indices, including neutrophil-to-eosinophil ratio (NER), leukocyte-to-eosinophil ratio (LER), eosinophil-to-lymphocyte ratio (ELR), and eosinophil-to-monocyte ratio (EMR).

Conditions

  • Acute Heart Failure
  • Reduced Systolic Function

Interventions

DIAGNOSTIC_TEST

eosinophil and other hematological parameters

Sponsors & Collaborators

  • Giresun University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-02
Primary Completion
2021-12-30
Completion
2022-04-05

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05410990 on ClinicalTrials.gov